focus -WSS

focus

author：entertainment 2025-10-02 21:07:25 - browse：2737

Enticed by the immense market opened by GLP-1 weight loss drugs Wegovy and Zepbound, a handful of biotech companies are trying to develop next-generation, longer-lasting therapies based on a very different approach: RNA interference.

This Nobel Prize-winning science works by degrading the biological blueprints that RNA use to make proteins — without the genetic instructions, the troublesome proteins are never made and the gene is essentially muted.

If the companies succeed, it would be a significant shift in the obesity treatment revolution, away from weekly drugs targeting hormones to medications that could be given much less frequently — twice a year or even less — and pinpoint genetic contributors to weight.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： A new study sees potential in DNA sequencing of infants

WSS

What PEPFAR has meant on the ground in Ukraine

Pregnancy discrimination could be enabled by AI

Iowa House, Senate pass 6

What causes an itch? Researchers may have solved the mystery

Study: Pain burden is higher in Black NFL players than white ones

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

explore

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

What PEPFAR has meant on the ground in Ukraine

Jerome Adams on the need for new antivirals for Covid

Congenital heart disease patients face new threat of heart failure

Medicare details structure of new drug price negotiation program

SCOTUS to consider access to abortion pill mifepristone

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Patients' immediate access to test results puts radiologists in a bind

23andMe had bad news about my health. I wish a person had delivered it

What PEPFAR has meant on the ground in Ukraine

entertainment

Pharma patents targeted by Biden in move to slash drug prices

Palantir health business leans on meeting customers’ needs

HCA discloses massive data breach affecting 11 million patients

What PEPFAR has meant on the ground in Ukraine

Elizabeth Holmes on track for early release from her 11

Why ADHD is under

entertainment

entertainment

focus

leisure time